CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,020,980 | +9.2% | 359,500 | 0.0% | 0.01% | +20.0% |
| Q2 2023 | $934,700 | +42.9% | 359,500 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $654,290 | +10.3% | 359,500 | 0.0% | 0.00% | +33.3% |
| Q4 2022 | $593,175 | -14.0% | 359,500 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $690,000 | -35.8% | 359,500 | 0.0% | 0.00% | -76.5% |
| Q2 2022 | $1,075,000 | – | 359,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,459,572 | $6,394,887 | 10.91% |
| BML Capital Management, LLC | 3,250,000 | $8,450,000 | 7.60% |
| Western Standard LLC | 524,050 | $1,362,530 | 1.17% |
| Newtyn Management, LLC | 1,358,049 | $3,530,927 | 0.83% |
| Novo Holdings A/S | 3,662,636 | $9,522,854 | 0.74% |
| Vazirani Asset Management LLC | 156,135 | $405,951 | 0.68% |
| Acuitas Investments, LLC | 329,173 | $855,850 | 0.50% |
| Anson Funds Management LP | 1,151,662 | $2,994,321 | 0.50% |
| Aldebaran Capital, LLC | 143,739 | $373,721 | 0.38% |
| Marquette Asset Management, LLC | 67,990 | $176,774 | 0.04% |